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The “danger theory” of Polly Matzinger
posed in 1994 (Matzinger, 1994) princi-
pally holds that the immune system is far
less concerned with “foreign” (microor-
ganisms, cells, and molecules) than with
signals that cause dangerous damage, and,
furthermore, that antigen-presenting cells
respond to danger signals—most notably
from cells undergoing stress and/or
injury—to initiate an immune response.
Of note, this theory strongly opposes the
long time prevalent self-/non-self discrim-
ination theory of immune responses that
has dominated immunological thinking
and acting for over 60 years.
Recently, the danger theory was empha-
sized in this journal by Pradeu and
Cooper who assessed the topic in view
of recently published experimental data
(Pradeu and Cooper, 2012). When reading
this article—quite admittedly with great
pleasure—, we spontaneously thought to
complement this thoughtfully and compe-
tently written paper by adding some notes
on our “injury hypothesis” as posed in
1994/1996 (Land et al., 1994; Land and
Messmer, 1996).
The injury hypothesis—which equals
the danger theory—is based on strin-
gent observations from a clinical trial in
kidney transplant patients that was con-
ducted during the late 1980s/early1990s,
that is, even more than 20 years ago.
Basically, the clinical data obtained from
this trial showed that mitigation of postis-
chemic allograft reperfusion injury by
intraoperative injection of a single dose of
the oxygen free radical scavenger “super-
oxide dismutase” results in a statistically
significant reduction in incidence of both
acute and chronic rejection events (Land
et al., 1994). From these convincing clin-
ical data, we concluded in terms of an
“argumentum e contrari” that tissue injury
(here: allograft injury) induces immunity
(here alloimmunity).
In fact, as recently pointed out by
Matzinger (Matzinger, 2012), these early
clinical observations can be regarded as the
true discovery of the danger model. In her
article, she wrote: “Walter Land, ex-head of
experimental surgery at the Medical School,
Munich, Germany was one of the first sur-
geons to understand the danger model. In a
way, he discovered it before I published it”
(Matzinger, 2012). (Of note, in 1994 and
thereafter, Walter Land was the Head of
the Division of Transplantation Surgery at
the Surgical University Clinic in Munich-
Grosshadern/Germany).
In the same article published by us in
1994 (Land et al., 1994), we extended our
concluding remarks to a working hypoth-
esis, today known as the injury hypoth-
esis. As illustrated and emphasized by a
frame within Figure 2 of this article, a
human biological immune system in its
own right was proposed that is activated by
non-pathogen-induced tissue injury (here:
allograft reperfusion injury) and that, after
activation, leads to the induction of an
adaptive immune response (here: adaptive
alloimmune response). In the center of this
immune system, besides others, we pro-
posed a role for antigen-presenting cells
(later appreciated to be dendritic cells)
activated by injury and subsequently lead-
ing to development of adaptive immunity,
that is, cells operating as a bridge between
injury and adaptive immunity. In other
words, as from where we stand today, in
1994 we had described the existence of a
human innate immune system activated
by tissue injury and preceding adaptive
immunity. But we missed to call the phe-
nomenon innate immunity. Interestingly
enough, that happened before the groups
of the Nobel Laureates Jules Hoffmann
(Lemaitre et al., 1996) and Bruce Beutler
(Poltorak et al., 1998) published the dis-
covery of “Toll” and “TLR4” [see also the
review of Cooper (Cooper, 2010)].
During subsequent years, the injury
hypothesis was extended and modified
several times (Land, 2002a,b, 2003a,b,
2005). Along with these modifications, the
concept of innate immunity was imple-
mented into organ transplantation. Thus,
in 2002, the possibility was discussed
that allograft reperfusion injury repre-
sents a case of innate immunity that
induces (“sterile”) inflammation medi-
ated by Toll-like receptors (e.g., TLR4)
interacting with heat shock proteins as
their agonists (Land, 2002a,b). In the
same year, we coined the term Innate
Alloimmunity (Land, 2002a) followed by
description of the term DAMPs in the
sense of damage-associated molecular pat-
terns a year later (Land, 2003b). Of note,
we proposed that oxidative stress to the
brain-dead donor organism as well as gen-
eration of reactive oxygen species during
reperfusion of the donor organ in the
recipient represent acute injurious events
to the allograft that, in turn, not only
lead to acute rejection but also contribute
to development of chronic rejection. In
particular, we suggested that activation
of donor- and recipient-derived innate
immune dendritic cells, via interaction of
DAMPs with TLRs, leads to initiation and
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induction of adaptive alloimmunity and,
further, activation of donor-derived innate
immune vascular cells, again via interac-
tion of DAMPs with TLRs, contributes to
development of alloatherosclerosis (Land,
2002a, 2005).
In more recently published review arti-
cles, we have updated the concept of
allograft injury-induced innate alloimmu-
nity (Land, 2012a,b,c). In one of these
articles, evidence is collected in sup-
port of the notion that prevention of
oxidative allograft injury may operate as
an efficient tool in the clinical situa-
tion to present alloantigens under subim-
munogenic conditions within an intragraft
non-inflammatory milieu, thereby poten-
tially generating tolerogenic dendritic cells
able to induce regulatory T cell-mediated
innate allotolerance (Land, 2012c).
Finally, the whole concept of the injury
hypothesis, in light of the international
literature on innate immunity currently
available, has been thoroughly and com-
prehensively discussed in a monograph
that was published as two parts in 2011
(Land, 2011a,b).
We thought it would be worthwhile
to provide the reader of Frontiers in
Immunology with this information about
the history of both, the danger theory and
the injury hypothesis as related to organ
transplantation; a note that may serve as a
useful addendum to the excellent article of
Pradeu and Cooper.
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